Macrophage-derived IGF-1 protects the neonatal intestine against necrotizing enterocolitis by promoting microvascular development

Commun Biol. 2022 Apr 6;5(1):320. doi: 10.1038/s42003-022-03252-9.

Abstract

Necrotizing enterocolitis (NEC) is a deadly bowel necrotic disease of premature infants. Low levels of plasma IGF-1 predispose premature infants to NEC. While increasing evidence suggests that defective perinatal intestinal microvascular development plays a role in NEC, the involved mechanism remains incompletely understood. We report here that serum and intestinal IGF-1 are developmentally regulated during the perinatal period in mice and decrease during experimental NEC. Neonatal intestinal macrophages produce IGF-1 and promote endothelial cell sprouting in vitro via IGF-1 signaling. In vivo, in the neonatal intestine, macrophage-derived IGF-1 promotes VEGF expression and endothelial cell proliferation and protects against experimental NEC. Exogenous IGF-1 preserves intestinal microvascular density and protects against experimental NEC. In human NEC tissues, villous endothelial cell proliferation and IGF-1- producing macrophages are decreased compared to controls. Together, our results suggest that defective IGF-1-production by neonatal macrophages impairs neonatal intestinal microvascular development and predisposes the intestine to necrotizing enterocolitis.

MeSH terms

  • Animals
  • Enterocolitis, Necrotizing* / metabolism
  • Enterocolitis, Necrotizing* / prevention & control
  • Female
  • Humans
  • Infant, Newborn
  • Insulin-Like Growth Factor I / metabolism
  • Intestines
  • Macrophages / metabolism
  • Mice
  • Pregnancy
  • Signal Transduction

Substances

  • IGF1 protein, human
  • insulin-like growth factor-1, mouse
  • Insulin-Like Growth Factor I